샘플 요청 목록

 카트 문의
시장보고서
상품코드
1933992

의료 실험실 정보 시스템 시장 : 컴포넌트, 도입, 시스템 유형, 용도, 최종사용자별 - 예측(2026-2032년)

Medical Laboratory Information System Market by Component, Deployment, System Type, Application, End User - Global Forecast 2026-2032
발행일: | 리서치사: 360iResearch | 페이지 정보: 영문 187 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

의료 실험실 저보 시스템 시장은 2025년에 15억 7,000만 달러로 평가되었습니다. 2026년에는 17억 7,000만 달러에 이르고, CAGR 9.66%로 성장을 지속하여 2032년까지 30억 1,000만 달러에 이를 것으로 예측되고 있습니다.

주요 시장 통계
기준 연도 : 2025년 15억 7,000만 달러
추정 연도 : 2026년 17억 7,000만 달러
예측 연도 : 2032년 30억 1,000만 달러
CAGR(%) 9.66%

현대의 검사 정보 시스템이 의료 분야의 임상 워크플로우, 컴플라이언스 체계 및 업무 성과를 어떻게 변화시키고 있는지 간략하게 소개합니다.

임상 워크플로우의 급속한 디지털화와 검사 효율화에 대한 끊임없는 추구로 인해 검사 정보 시스템(LIS)은 의료 서비스 제공업체의 전략적 핵심 기술로 승화되었습니다. 현대의 LIS 플랫폼은 더 이상 고립된 트랜잭션 처리 장치로 기능하는 것이 아닙니다. 장비 연결성, 임상 의사결정 지원, 검사 업무 분석을 통합적으로 조정하는 허브 역할을 하고 있습니다. 그 결과, 견고한 LIS 도입을 우선시하는 의료기관에서는 검체 처리 시간 단축, 오류 감소, 전자건강기록(EHR)과의 상호운용성에서 측정 가능한 개선이 확인되었습니다.

검사 정보 시스템을 재정의하고, 진단이 임상 진료를 지원하는 방식을 재구성하고, 새로운 기술적, 운영적, 규제적 변화를 재구성합니다.

검사 정보학의 영역은 기술 혁신, 규제 압력, 새로운 임상 협력 모델로 인해 혁신적인 변화를 겪고 있습니다. 클라우드 네이티브 아키텍처와 마이크로서비스는 신속한 기능 배포, 확장성, 다중 위치 간 협업을 가능하게 하며, 엣지 컴퓨팅과 검증된 통합은 장비로부터의 실시간 데이터 피드와 로컬 내결함성을 보장합니다. 벤더들은 점점 더 모듈식 접근 방식을 채택하고 있으며, 실험실에서 베스트 오브 블레드 구성 요소를 조립하고 특수 라우팅, 검증 및 분석을 위한 미들웨어를 통합할 수 있도록 하고 있습니다.

2025년 관세정책 변경이 의료기관의 검사정보시스템 조달, 공급 연속성, 도입 전략에 미치는 영향 분석

2025년에 도입된 개정 관세 조치는 검사 정보 시스템 도입에 필수적인 하드웨어, 서버, 전용 워크스테이션을 수입하는 기관에 운영 및 조달 측면에서 복잡한 문제들을 야기했습니다. 조달팀은 총소유비용(TCO)과 공급업체 선정에 대한 감시가 강화됨에 따라 조달 전략과 공급업체 계약을 재평가해야 하는 상황에 직면했습니다. 이에 따라 일부 검사실은 핵심 하드웨어 부품의 전략적 비축을 가속화하고, 다른 한편으로는 공급망 변동 위험을 줄이기 위해 공급업체 통합 및 장기 서비스 계약을 우선시하는 움직임이 나타났습니다.

용도, 최종 사용자, 구성요소, 도입 형태, 시스템 유형별 차이가 다양한 검사정보시스템의 요구사항과 도입 경로를 어떻게 결정하는지 파악할 수 있는 세부 세분화 분석

부문별 동향은 용도, 최종사용자, 구성요소, 도입 형태, 시스템 유형별로 도입 패턴의 차이와 솔루션 요구사항에 대한 차이를 보여줍니다. 용도 측면에서 임상화학, 혈액학, 면역학, 미생물학은 각각 다른 워크플로우, 데이터 수집, 기기 통합에 대한 요구가 있어 설정 가능한 규칙 엔진과 전문 결과 검증 모듈에 대한 수요가 증가하고 있습니다. 따라서 임상화학 및 미생물학 처리량이 많은 검사실에서는 강력한 검체 추적 기능과 기기 인터페이스 기능이 요구됩니다. 반면, 혈액학 환경에서는 자동 플래그 설정 및 반사 검사 워크플로우가 우선시됩니다.

지역별 비교 분석을 통해 규제 프레임워크, 인프라 구축 현황, 임상적 우선순위가 세계 시장에서 검사 정보 시스템(LIS) 도입을 어떻게 형성하고 있는지를 파악할 수 있습니다.

지역별 동향은 미주, 유럽, 유럽, 중동 및 아프리카, 아시아태평양의 구매자의 우선순위와 도입 모델을 형성하고 있으며, 각 지역별 규제 환경, IT 성숙도, 임상 워크플로우가 상이하게 나타나고 있습니다. 미국 대륙에서는 대규모 통합 의료 시스템과 분산형 진단 네트워크가 전자 건강 기록 및 지역 주민 건강 관리 이니셔티브와 원활하게 통합되는 확장성과 상호 운용성을 갖춘 플랫폼을 선호합니다. 그 결과, 벤더와 구매자는 기관 간 데이터 교환을 지원하기 위해 표준 기반의 연결성과 보안 체계를 중요시하고 있습니다.

상호운용성, 모듈형 아키텍처, 지역 특화 서비스 모델을 중시하는 주요 경쟁사 및 벤더 전략으로 복잡한 검사 업무의 니즈 충족

검사정보시스템 생태계의 주요 기업들은 진화하는 검사 요구에 대응하기 위해 상호운용성, 모듈형 아키텍처, 서비스 품질에 대한 투자를 통해 차별화를 꾀하고 있습니다. 시장 선도 기업들은 통합 기간을 단축하고 도입 리스크를 줄이기 위해 강력한 API, 인증된 기기 커넥터, 구성 가능한 워크플로우 엔진 개발에 주력하고 있습니다. 또한, 예측 가능한 운영 결과를 제공하기 위해 전문 서비스 및 관리형 지원, 특히 다기관 검사 네트워크 및 병원 시스템을 위한 전문 서비스 및 관리형 지원 제공을 확대하고 있습니다.

검사, IT, 조달 부서의 리더를 위한 실용적인 제안: LIS 도입 가속화, 탄력성 강화, 측정 가능한 운영 개선 실현을 위해

업계 리더은 실험실 워크플로우의 진화에 따라 운영 가치를 창출하고 경쟁 우위를 유지하기 위해 단호한 조치를 취해야 합니다. 우선, 거버넌스와 이해관계자간 협업을 최우선적으로 고려해야 합니다. 검사실 책임자, IT 리더, 임상의사, 조달팀이 공동으로 임상적 필요성과 기술적 타당성의 균형을 맞추는 도입 기준을 수립해야 합니다. 다학제적 운영위원회 설치는 의사결정을 가속화하고, 도입이 임상 경로 및 인증 요건에 부합하도록 보장합니다.

검사정보학 의사결정권자를 위한 증거 기반 지식 창출을 위해 채택한 혼합 연구 방법, 이해관계자 참여, 데이터 검증 기술에 대해 투명하게 설명합니다.

본 Executive Summary를 뒷받침하는 조사방법은 정성적, 정량적 접근법을 결합하여 증거에 기반한 인사이트와 실무적 연관성을 확보했습니다. 주요 정보원으로는 검사실 책임자, IT 리더, 조달 전문가, 벤더 제품 관리자를 대상으로 구조화된 인터뷰를 실시하여 도입 과제, 통합 우선순위, 서비스 기대치에 대한 직접적인 견해를 수집했습니다. 2차 자료로는 기술 백서, 규제 지침 문서, 표준 사양서, 피어 리뷰 문헌을 활용하여 워크플로우 패턴과 컴플라이언스 고려 사항을 확인했습니다.

전략적 LIS 도입, 거버넌스 및 통합 관행이 어떻게 검사 업무를 혁신하고 임상적 우수성을 지원하는지를 뒷받침하는 개요

결론적으로, 검사정보시스템(LIS)은 임상 품질, 업무 효율성, 컴플라이언스를 실현하는 전략적 기반으로 진화했습니다. 현대의 LIS 플랫폼은 기기 생태계를 통합하고 고급 분석을 지원하며 검사 워크플로우를 보다 광범위한 의료 서비스 제공 시스템에 연결합니다. 기술 및 규제 요구사항이 계속 진화하는 가운데, 성공적인 도입은 서비스 연속성과 검증된 통합, 부서 간 거버넌스, 모듈형 아키텍처, 그리고 실용적인 조달 전략에 달려있습니다.

자주 묻는 질문

  • 의료 실험실 정보 시스템 시장 규모는 어떻게 예측되나요?
  • 검사 정보 시스템이 의료 분야의 임상 워크플로우에 미치는 영향은 무엇인가요?
  • 2025년 관세정책 변경이 검사 정보 시스템 도입에 미치는 영향은 무엇인가요?
  • 검사 정보 시스템의 용도에 따른 요구사항은 어떻게 다른가요?
  • 지역별 검사 정보 시스템 도입의 차이는 무엇인가요?
  • 검사 정보 시스템 생태계의 주요 기업들은 어떤 전략을 취하고 있나요?

목차

제1장 서문

제2장 조사 방법

제3장 주요 요약

제4장 시장 개요

제5장 시장 인사이트

제6장 미국의 관세의 누적 영향, 2025

제7장 AI의 누적 영향, 2025

제8장 의료 실험실 정보 시스템 시장 : 컴포넌트별

제9장 의료 실험실 정보 시스템 시장 : 전개 형태별

제10장 의료 실험실 정보 시스템 시장 시스템 유형별

제11장 의료 실험실 정보 시스템 시장 : 용도별

제12장 의료 실험실 정보 시스템 시장 : 최종사용자별

제13장 의료 실험실 정보 시스템 시장 : 지역별

제14장 의료 실험실 정보 시스템 시장 : 그룹별

제15장 의료 실험실 정보 시스템 시장 : 국가별

제16장 미국의 의료 실험실 정보 시스템 시장

제17장 중국의 의료 실험실 정보 시스템 시장

제18장 경쟁 구도

LSH 26.03.09

The Medical Laboratory Information System Market was valued at USD 1.57 billion in 2025 and is projected to grow to USD 1.77 billion in 2026, with a CAGR of 9.66%, reaching USD 3.01 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.57 billion
Estimated Year [2026] USD 1.77 billion
Forecast Year [2032] USD 3.01 billion
CAGR (%) 9.66%

A concise introduction to how modern laboratory information systems are transforming clinical workflows, compliance frameworks, and operational outcomes in healthcare

The rapid digitization of clinical workflows and the relentless drive for laboratory efficiency have elevated Laboratory Information Systems into a strategic technology centerpiece for healthcare providers. Modern LIS platforms no longer function as isolated transaction processors; they serve as integration hubs that orchestrate instrument connectivity, clinical decision support, and laboratory operational analytics. As a result, institutions that prioritize robust LIS adoption observe measurable improvements in sample turnaround, error reduction, and interoperability with electronic health records.

Moreover, regulatory requirements and quality standards continue to mandate precise traceability and documentation across laboratory processes. In response, vendors are embedding audit trails, configurable workflows, and compliance modules directly into core offerings. Consequently, laboratory leadership must evaluate LIS solutions not simply on technical features but on their capacity to support evolving accreditation standards and dynamic clinical pathways.

Transitioning to contemporary LIS architectures involves cultural change as much as technical deployment. Cross-functional alignment among laboratory directors, IT, procurement, and clinical stakeholders is essential to ensure that adoption delivers operational value and clinical reliability. Ultimately, the objective is to transform the laboratory from a cost center into a measurable contributor to patient outcomes and institutional efficiency through intelligent LIS deployment.

Emerging technological, operational, and regulatory shifts that are redefining laboratory information systems and reshaping how diagnostics support clinical care

The landscape of laboratory informatics is undergoing transformative shifts driven by technological advances, regulatory pressures, and new models of clinical collaboration. Cloud-native architectures and microservices are enabling rapid feature deployment, scalability, and multi-site orchestration, while edge computing and validated integrations ensure real-time instrument feeds and local resilience. Vendors increasingly adopt modular approaches that allow laboratories to assemble best-of-breed components and integrate middleware for specialized routing, validation, and analytics.

Concurrently, interoperability standards and APIs facilitate closer alignment between LIS, electronic health records, and population health platforms. This connectivity supports faster diagnostic loops and better-informed clinician decision-making. As artificial intelligence and advanced analytics mature, they will augment quality control, anomaly detection, and predictive maintenance functions, thereby reducing downtime and improving throughput. These innovations require laboratories to adopt governance frameworks that balance agility with data integrity and patient safety.

Finally, shifting care models-such as decentralized testing and community-based diagnostics-are redefining throughput patterns and data flows. Vendors and laboratory managers must adapt by designing deployment strategies that accommodate distributed testing locations, heterogeneous instrumentation, and evolving user expectations, ensuring that the LIS remains the central orchestrator of laboratory operations across diverse care settings.

Analysis of how changes in tariff policies in 2025 reshaped procurement, supply continuity, and deployment strategies for laboratory information systems across healthcare institutions

The introduction of revised tariff measures in 2025 created a complex set of operational and procurement challenges for institutions that import hardware, servers, and specialized workstations essential to laboratory information system deployments. Procurement teams faced increased scrutiny around total cost of ownership and supplier selection, prompting a re-evaluation of sourcing strategies and vendor agreements. In response, some laboratories accelerated strategic stockpiling of critical hardware components while others prioritized vendor consolidation and long-term service contracts to mitigate supply chain volatility.

At the same time, service models shifted toward a heavier reliance on local installation and support capabilities to avoid customs and import-related delays. Organizations invested more in training internal teams and in partnering with regional integrators to preserve deployment timelines and ensure continuity of mission-critical services. These operational adjustments also influenced deployment preferences, with several institutions favoring cloud-based software and subscription services to reduce on-premise hardware dependencies and the complexity of cross-border logistics.

Furthermore, the tariff environment underscored the importance of flexible procurement clauses and contingency planning. Laboratory leaders incorporated scenario-based risk assessments into capital planning processes and worked closely with vendors to negotiate multi-year maintenance agreements that included clauses for hardware replacement, remote diagnostics, and warranty extensions, thereby enhancing resilience against future trade disruptions.

In-depth segmentation insights revealing how application, end user, component, deployment, and system type distinctions drive diverse laboratory information system requirements and adoption paths

Segment-specific dynamics reveal differentiated adoption patterns and solution requirements across application, end user, component, deployment, and system type categories. In terms of application, clinical chemistry, hematology, immunology, and microbiology impose distinct workflow, data capture, and instrumentation integration needs, driving demand for configurable rule engines and specialized result validation modules. Consequently, laboratories with heavy clinical chemistry or microbiology throughput require robust sample tracking and instrument interfacing capabilities, whereas hematology environments prioritize automated flagging and reflex testing workflows.

Examining end users, diagnostic labs, hospitals, and research institutes each follow unique procurement and governance models. Diagnostic laboratories often emphasize throughput and regulatory compliance, hospitals focus on interoperability with clinical systems and turnaround time for inpatient care, and research institutes seek flexible data export and custom analytics for study protocols. These differences influence vendor engagement strategies and implementation roadmaps.

Component-level segmentation highlights that hardware, services, and software form the backbone of viable solutions. Hardware categories such as servers and workstations must meet performance and redundancy specifications, services including installation and support ensure operational continuity, and software components-both LIS software and middleware-provide the functional capability to manage results, orders, and instrument orchestration. Deployment choices across cloud and on-premise environments present trade-offs: private and public cloud models offer scalability and reduced infrastructure burden, while traditional and virtual on-premise deployments deliver control and predictable latency. Lastly, system type considerations between integrated and standalone offerings determine the extent to which laboratories can centralize workflows, enforce standardized protocols, and adopt incremental modernization strategies.

Comparative regional analysis highlighting how regulatory frameworks, infrastructure readiness, and clinical priorities shape laboratory information system adoption across global markets

Regional dynamics shape buyer priorities and implementation models across the Americas, Europe, Middle East & Africa, and Asia-Pacific, with each region exhibiting distinct regulatory environments, IT maturity, and clinical workflows. In the Americas, large integrated health systems and decentralized diagnostic networks favor scalable, interoperable platforms that integrate seamlessly with electronic health records and population health initiatives. Consequently, vendors and purchasers emphasize standards-based connectivity and security posture to support cross-institutional data exchange.

In Europe, Middle East & Africa, the regulatory mosaic and diverse healthcare delivery models influence solution selection and deployment pace. GDPR-like privacy frameworks, local accreditation standards, and multilingual support requirements encourage modular implementations and localized service partnerships. Meanwhile, the Asia-Pacific region demonstrates rapid adoption of digital health initiatives, coupled with significant investments in laboratory modernization; buyers often pursue hybrid deployment models that balance cloud agility with on-premise control to accommodate network variability and national data residency mandates.

Across all regions, transitional phrases such as meanwhile and consequently highlight the interplay between regulatory drivers and infrastructure readiness, underscoring the need for adaptable service models, regional implementation expertise, and vendor ecosystems capable of supporting multi-jurisdictional rollouts and long-term operational sustainability.

Key competitive dynamics and vendor strategies that emphasize interoperability, modular architectures, and localized service models to meet complex laboratory operational needs

Key companies in the laboratory information systems ecosystem are differentiating through investments in interoperability, modular architectures, and service excellence to meet evolving laboratory needs. Market leaders focus on developing robust APIs, certified instrument connectors, and configurable workflow engines that reduce integration timelines and lower total implementation risk. They also expand professional services and managed support offerings to deliver predictable operational outcomes, particularly for multi-site laboratory networks and hospital systems.

Strategic partnerships and channel expansions have become essential to extend geographic reach and to provide localized installation and support. Vendors are increasingly collaborating with instrument manufacturers, middleware specialists, and cloud service providers to build validated stacks that simplify procurement and reduce validation complexity for regulated environments. At the same time, some companies pursue niche specialization, concentrating on high-volume disciplines such as microbiology or hematology to deliver depth in functionality and domain-specific analytics.

Competitive advantage is often determined by the ability to demonstrate proven implementations, flexible commercialization models, and a clear roadmap for regulatory compliance and cybersecurity. Strengthening these capabilities helps vendors address the operational realities of modern laboratories while enabling customers to deploy systems that support clinical quality and laboratory efficiency.

Actionable recommendations for laboratory, IT, and procurement leaders to accelerate LIS adoption, strengthen resilience, and secure measurable operational improvements

Industry leaders should act decisively to capture operational value and maintain competitive positioning as laboratory workflows evolve. First, governance and stakeholder alignment must be prioritized; laboratory directors, IT leaders, clinicians, and procurement teams should co-develop deployment criteria that balance clinical imperatives with technical feasibility. Establishing multidisciplinary steering committees accelerates decision-making and ensures deployments align with clinical pathways and accreditation requirements.

Next, technical strategies should emphasize modular, standards-based architectures and validated integrations. Leaders should require vendors to provide documented APIs, instrument connectors, and security attestations, and to support phased rollouts that de-risk large-scale transitions. Moreover, investing in staff training, change management, and knowledge transfer will reduce operational disruptions and maximize adoption.

Finally, procurement strategies must incorporate service continuity and resilience. Negotiations should include robust service-level agreements, remote diagnostics, and provisions for local support and spare parts. By implementing these measures, organizations will strengthen operational resilience, shorten time-to-value, and ensure the laboratory remains a reliable partner in patient care delivery.

A transparent explanation of the mixed-methods research approach, stakeholder engagement, and data validation techniques used to generate evidence-based insights for laboratory informatics decision-makers

The research methodology informing this executive summary combined qualitative and quantitative approaches to ensure evidence-based insights and practical relevance. Primary inputs included structured interviews with laboratory directors, IT leaders, procurement specialists, and vendor product managers, providing first-hand perspectives on deployment challenges, integration priorities, and service expectations. Secondary sources included technical white papers, regulatory guidance documents, standards specifications, and peer-reviewed literature to validate workflow patterns and compliance considerations.

Data synthesis emphasized triangulation to reconcile differing stakeholder views and to identify persistent operational constraints. Case study analysis of exemplar implementations offered concrete lessons on governance models, phased rollouts, and validation strategies. In addition, vendor capability assessments evaluated integration readiness, API maturity, and service delivery models to illuminate practical procurement criteria. Throughout the methodology, ethical considerations and data privacy practices guided information collection and handling, ensuring that proprietary data and stakeholder confidentiality were respected.

A concluding synthesis that reinforces how strategic LIS adoption, governance, and integration practices transform laboratory operations and support clinical excellence

In conclusion, laboratory information systems have evolved into strategic enablers of clinical quality, operational efficiency, and compliance. Modern LIS platforms integrate instrument ecosystems, support advanced analytics, and connect laboratory workflows to broader care delivery systems. As technology and regulatory demands continue to advance, successful adoption depends on cross-functional governance, modular architectures, and pragmatic procurement strategies that emphasize service continuity and validated integrations.

Laboratory leaders must therefore adopt a proactive posture: align stakeholders early, prioritize standards-based interoperability, and negotiate service agreements that mitigate operational risk. Vendors and integrators should continue to invest in localized support capabilities and certified instrument partnerships to ensure predictable deployments. By balancing technical innovation with disciplined implementation practices, healthcare organizations can transform laboratory operations into resilient, data-driven contributors to patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Laboratory Information System Market, by Component

  • 8.1. Component
    • 8.1.1. Hardware
      • 8.1.1.1. Servers
      • 8.1.1.2. Workstations
    • 8.1.2. Services
      • 8.1.2.1. Installation
      • 8.1.2.2. Support
    • 8.1.3. Software
      • 8.1.3.1. LIS Software
      • 8.1.3.2. Middleware

9. Medical Laboratory Information System Market, by Deployment

  • 9.1. Deployment
    • 9.1.1. Cloud
      • 9.1.1.1. Private Cloud
      • 9.1.1.2. Public Cloud
    • 9.1.2. On-Premise
      • 9.1.2.1. Traditional
      • 9.1.2.2. Virtual

10. Medical Laboratory Information System Market, by System Type

  • 10.1. System Type
    • 10.1.1. Integrated
    • 10.1.2. Standalone

11. Medical Laboratory Information System Market, by Application

  • 11.1. Application
    • 11.1.1. Clinical Chemistry
    • 11.1.2. Hematology
    • 11.1.3. Immunology
    • 11.1.4. Microbiology

12. Medical Laboratory Information System Market, by End User

  • 12.1. End User
    • 12.1.1. Diagnostic Labs
    • 12.1.2. Hospitals
    • 12.1.3. Research Institutes

13. Medical Laboratory Information System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Laboratory Information System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Laboratory Information System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical Laboratory Information System Market

17. China Medical Laboratory Information System Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Autoscribe Informatics
  • 18.7. Clinisys Group Ltd
  • 18.8. Comp Pro Med Inc
  • 18.9. CompuGroup Medical SE & Co. KGaA
  • 18.10. Dedalus Group SpA
  • 18.11. Epic Systems Corporation
  • 18.12. LabVantage Solutions Inc
  • 18.13. LabWare Inc
  • 18.14. LigoLab
  • 18.15. McKesson Corporation
  • 18.16. Medical Information Technology Inc
  • 18.17. Meditech
  • 18.18. Merge Healthcare Inc
  • 18.19. Oracle Corporation
  • 18.20. Orchard Software Corporation
  • 18.21. PerkinElmer Inc
  • 18.22. Roper Technologies
  • 18.23. SCC Soft Computer LLC
  • 18.24. Siemens Healthineers AG
  • 18.25. Sysmex Corporation
  • 18.26. Thermo Fisher Scientific Inc
  • 18.27. XIFIN Inc
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제